The Diagnostics Advisory Committee discussed the focus of the evaluation and the evidence available for faecal calprotectin testing. It noted that evidence existed on faecal calprotectin testing in ...
SALEM, N.H., May 8, 2025 /PRNewswire/ -- American Laboratory Products Company, Ltd. ("ALPCO"), a global provider of specialty diagnostic solutions, announced the European commercial launch of its ...
High levels of calprotectin indicate IBD, while low or normal levels indicate IBS. In the United States, an estimated 3.1 million adults have been diagnosed with IBD. Currently, fecal calprotectin ...
Fecal calprotectin is a highly sensitive assay that measures inflammation present in the intestinal tract. Gastroenterologists are increasingly ordering fecal calprotectin to screen and monitor ...
Research from the University of Wisconsin adds to the evidence that gut inflammation may be linked to cognitive decline.
BÜHLMANN, a company based in Germany, launched IBDoc, an at-home, in-vitro diagnostic test for gastrointestinal conditions, including some inflammatory bowel diseases, according to an IBD News Today ...
The External Assessment Group did a systematic review of the evidence on cost effectiveness for faecal calprotectin testing and constructed a de novo economic model. The outcomes of interest for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results